Dengue Fever News and Research

RSS
Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. Symptoms typically begin three to fourteen days after infection. These may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin rash.
WRAIR researchers publish results from Plasmodium vivax malaria vaccine study

WRAIR researchers publish results from Plasmodium vivax malaria vaccine study

Zika virus can cross the placental barrier, according to new study

Zika virus can cross the placental barrier, according to new study

ESCMID gathers more solid data to better assess Zika virus risks, prepares for possible outbreak in Africa, Europe

ESCMID gathers more solid data to better assess Zika virus risks, prepares for possible outbreak in Africa, Europe

El Niño plays significant role in outbreak of haemorrhagic fevers

El Niño plays significant role in outbreak of haemorrhagic fevers

Zika virus threat across the Americas

Zika virus threat across the Americas

Zika virus expected to spread across the U.S., says WHO

Zika virus expected to spread across the U.S., says WHO

A Thai man with Zika virus has been hospitalized in Taiwan

A Thai man with Zika virus has been hospitalized in Taiwan

Large-scale clinical trial to evaluate dengue vaccine launched in Brazil

Large-scale clinical trial to evaluate dengue vaccine launched in Brazil

Simplified mathematical model to study spread of dengue fever in urban areas

Simplified mathematical model to study spread of dengue fever in urban areas

Findings show promising evidence for creating broad-spectrum antiviral

Findings show promising evidence for creating broad-spectrum antiviral

SLU researcher discovered world's first dengue vaccine

SLU researcher discovered world's first dengue vaccine

Oxitec prepares to increase supplies of OX513A to address recent outbreak of Zika virus in Brazil

Oxitec prepares to increase supplies of OX513A to address recent outbreak of Zika virus in Brazil

Researchers test effectiveness of commercially available mosquito repellents

Researchers test effectiveness of commercially available mosquito repellents

Infections experienced in childhood may lead to premature ACS or heart attacks

Infections experienced in childhood may lead to premature ACS or heart attacks

Native Antigen Co. announces the launch of a new range of Dengue Virus-Like Particles

Native Antigen Co. announces the launch of a new range of Dengue Virus-Like Particles

First-ever genomic study shows dengue may survive year-round in southern China

First-ever genomic study shows dengue may survive year-round in southern China

Health Partnership Scheme funds project dedicated to viral haemorrhagic fever

Health Partnership Scheme funds project dedicated to viral haemorrhagic fever

Academies and DFG point out limitations and risks of new genome editing techniques

Academies and DFG point out limitations and risks of new genome editing techniques

Specialized proteins can inhibit HIV

Specialized proteins can inhibit HIV

60P to commence Phase II clinical trial among dengue fever patients

60P to commence Phase II clinical trial among dengue fever patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.